Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Cobimetinib +/- Venetoclax +/- Atezolizumab in RRMM
NCT03312530Phase 2Completed
- Sponsor
- Roche
- Start
- Nov 2017
- Primary completion
- May 2021
- Modality
- Small Molecules
- Countries
- 9
01
Overview
A Phase 2 trial of cobimetinib in multiple myeloma (MM), sponsored by Roche. Started Nov 2017; status: completed.
02
Drugs
cobimetinib
03
Conditions
multiple myeloma (MM)
Beyond the preview
Go deeper on NCT03312530.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03312530.